Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.30 |
| ▸ | ACE | P12821 | 2/20 | 0.30 |
| ▸ | CPA1 | P15085 | 2/20 | 0.30 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL382996 | 0.81 | TSHR (0.35) | MMEACECPA1ACE2 | |
| SCHEMBL23350792 | 0.81 | TSHR (0.35) | MMEACECPA1ACE2 | |
| SCHEMBL13624877 | 0.79 | MME (0.31) | MMEACECPA1ACE2 | |
| SCHEMBL10314806 | 0.78 | — | — | |
| SCHEMBL14224840 | 0.77 | MME (0.30) | MMEACECPA1ACE2 | |
| SCHEMBL4975439 | 0.75 | — | — | |
| SCHEMBL23207 | 0.74 | — | — | |
| SCHEMBL12838304 | 0.72 | — | — | |
| SCHEMBL25995414 | 0.67 | — | — | |
| SCHEMBL23373488 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8334420-B2 | Selectivity for hexene and octene from ethylene; polymerization inhibitor containing chromium, titanium and vanadium | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2012-12-18 | — | — | US | disclosed |
| US-20120172645-A1 | Olefin Oligomerization catalysts and Methods of Making and Using Same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2012-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120172645-A1 | Olefin Oligomerization catalysts and Methods of Making and Using Same | COG7, COG8, COG4 | MME 2191/4885ACE 2967/4885CPA1 4043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.